Qing Liu
South China Agricultural University(CN)Central South University of Forestry and Technology(CN)Central South University(CN)Xinjiang Medical University(CN)Harbin Medical University(CN)Capital Medical University(CN)Xiamen University(CN)Peking University(CN)Sir Run Run Shaw Hospital(CN)First Affiliated Hospital of Xinjiang Medical University(CN)Beijing Jishuitan Hospital(CN)Southwest Medical University(CN)Shantou University(CN)First Affiliated Hospital of Xiamen University(CN)Ganzhou People's Hospital(CN)Shantou University Medical College(CN)Hunan Xiangdian Test Research Institute (China)(CN)First Affiliated Hospital of GuangXi Medical University(CN)Zhejiang Provincial People's Hospital(CN)Second Affiliated Hospital of Harbin Medical University(CN)Hunan Entry-Exit Inspection and Quarantine Bureau(CN)Affiliated Hospital of Hebei University(CN)Hunan Institute of Mental Health(CN)Xiangya Hospital Central South University(CN)Analysis Group (United States)(US)
Publications by Year
Research Areas
Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, RNA modifications and cancer, MicroRNA in disease regulation, Glioma Diagnosis and Treatment
Most-Cited Works
- → Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma(2018)216 cited
- → A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide(2009)190 cited
- → Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway(2022)183 cited
- → LncRNA CASC2 Interacts With miR‐181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway(2017)174 cited
- → A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses(2019)80 cited
- → Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments(2019)77 cited